21 results
8-K
EX-99.1
NMRD
Nemaura Medical Inc
18 Mar 20
Nemaura To Prepare for Launch of sugarBEAT® CGM In the U.S. Following FDA Feedback
4:07pm
scale, and from a diverse patient demographic, that we believe has never previously been achieved using CGM. Nemaura intends to use this data to develop
424B5
NMRD
Nemaura Medical Inc
19 Oct 18
Prospectus supplement for primary offering
4:04pm
centres around the world to cover a wide demographic – including Asia and Europe – and is managed by our in-house management team.
We had 2 pre
424B5
NMRD
Nemaura Medical Inc
10 Apr 19
Prospectus supplement for primary offering
4:35pm
by contract clinical research organizations in various centres around the world to cover a wide demographic – including Asia and Europe – and is managed
424B5
NMRD
Nemaura Medical Inc
19 Dec 18
Prospectus supplement for primary offering
5:09pm
research organizations in various centres around the world to cover a wide demographic – including Asia and Europe – and is managed by our in-house
424B5
NMRD
Nemaura Medical Inc
17 Dec 18
Prospectus supplement for primary offering
4:57pm
testing is conducted by contract clinical research organizations in various centres around the world to cover a wide demographic – including Asia
10-K
s0l tfmq94c
23 Jun 15
Annual report
12:00am
424B8
0kct0
11 Sep 23
Prospectus unintentially filed late
4:41pm
POS AM
afaiycv
3 Aug 23
Prospectus update (post-effective amendment)
4:08pm
424B3
og2 s4m6boa1obbq2z
17 Nov 14
Prospectus supplement
12:00am
424B4
6pxgq8obcjz
15 May 23
Prospectus supplement with pricing info
4:31pm